Su-Jiao Qi

Su-Jiao Qi

Auto-generated profile, based on publicly available information

Su-Jiao Qi

Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2017 in Molecules
Verified
Journal Article
Open access
PDF file
LFLi Fengran
Li Fengran
ZFzhanfang fan
zhanfang fan
SQSu-Jiao Qi
Su-Jiao Qi
YWYan-Shi Wang
Yan-Shi Wang
JWJian Wang
Jian Wang
MCMao-Sheng Cheng
Mao-Sheng Cheng
A series of novel N-substituted-β-d-glucosamine derivatives that incorporate benzenesulfonamides were designed using a fragment-based drug design strategy. Each derivative was synthesized and evaluated in vitro for its inhibitory activity against human carbonic anhydrase (hCA) IX; several derivatives displayed desirable potency profiles against this enzyme. The molecular docking studies provided the design rationale and predicted potential binding modes for carbonic anhydrase (CA) IX and three target compounds, including the most potent inhibitor, compound 7f (IC50 = 10.01 nM). Moreover, the calculated Log P (cLog P) values showed that all the compounds tended to be hydrophilic. In addition, topological polar surface area (TPSA) value-based predictions highlighted the selectivity of these carbohydrate-based inhibitors for membrane-associated CA IX.